A 42-year-old woman with a 4-month history of progressive dorsal back pain and constitutional symptoms (fever, weight loss) is suspected to have Pott disease on clinical grounds. MRI confirms anterior vertebral body involvement with epidural granulation tissue. Which investigation is most appropriate for microbiological confirmation and drug susceptibility testing?

Explanation

## Microbiological Confirmation in Pott Disease ### Why Percutaneous Needle Biopsy is the Gold Standard **Key Point:** Percutaneous needle biopsy of the affected vertebral body is the investigation of choice for microbiological confirmation of Pott disease and drug susceptibility testing (DST). It provides tissue for culture, histopathology, and molecular testing (GeneXpert MTB/RIF). ### Diagnostic Yield and Advantages | Method | Sensitivity | Specificity | Advantages | Limitations | |--------|-------------|-------------|-----------|-------------| | Percutaneous needle biopsy | 60–90% | >95% | Direct tissue, culture, DST, histology, GeneXpert | Invasive, requires expertise | | Sputum smear/culture | 10–20% | High | Non-invasive | Low yield in spinal TB (extrapulmonary) | | Blood culture | <5% | High | Non-invasive | Very low yield in TB | | CSF analysis | Not applicable | Not applicable | For TB meningitis only | Irrelevant for spinal TB | **High-Yield:** Percutaneous needle biopsy under CT or fluoroscopic guidance achieves: - **Culture confirmation:** Gold standard for diagnosis - **Drug susceptibility testing (DST):** Essential for detecting MDR-TB and XDR-TB - **Histopathology:** Caseating granulomas confirm TB - **GeneXpert MTB/RIF:** Rapid (2 hours), detects rifampicin resistance - **Nucleic acid amplification tests (NAAT):** High sensitivity, rapid results ### Clinical Pearl **Clinical Pearl:** In extrapulmonary TB (like Pott disease), sputum samples are often negative because the infection is localized to the spine, not the lungs. Tissue biopsy from the affected site is essential for diagnosis. GeneXpert MTB/RIF on biopsy material is now WHO-recommended for rapid diagnosis and detection of rifampicin resistance. ### Why Other Investigations Fail **Sputum smear microscopy and culture:** - Only 10–20% yield in extrapulmonary TB - Patient may not have pulmonary involvement - Not suitable for spinal TB diagnosis **Blood culture:** - TB bacteremia is rare (<5% of cases) - Very low sensitivity for diagnosis - Not recommended for spinal TB **CSF analysis:** - Relevant only for TB meningitis - Completely inappropriate for Pott disease - May be normal in spinal TB without meningeal involvement ### Procedure Details **Biopsy technique:** - CT or fluoroscopic guidance (safer, higher yield) - Needle aspiration or core biopsy - Send for: culture (liquid and solid media), histopathology, GeneXpert MTB/RIF, NAAT - Culture takes 2–8 weeks; GeneXpert gives results in 2 hours **Warning:** Do NOT delay anti-TB therapy while awaiting culture results if clinical and radiological suspicion is high. Start therapy based on MRI findings and clinical presentation; culture/DST refine the regimen later. ### Mnemonic for Pott Disease Confirmation **BIOPSY-TB:** **B**iopsy for diagnosis, **I**nvasive but accurate, **O**btain tissue, **P**CR/GeneXpert rapid, **S**ensitivity high, **Y**ield 60–90%, **T**issue culture gold standard, **B**acteriology confirms TB.